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Background: Surveys enquiring about burden of headache over a prior period of time (eg, 3 months) are subject
to recall bias. To eliminate this as far as possible, we focused on presence and impact of headache on the
preceding day (“headache yesterday”).
Methods: Adults (18-65 years) were surveyed from the general populations of Germany, Italy, Lithuania,
Luxembourg and the Netherlands, from a work-force population in Spain and from mostly non-headache patient
populations of Austria, France and UK. A study of non-responders in some countries allowed detection of potential
participation bias where initial participation rates were low.
Results: Participation rates varied between 11% and 59% (mean 27%). Non-responder studies suggested that,
because of participation bias, headache prevalence might be overestimated in initial responders by up to 2%
(absolute). Across all countries, 1,422 of 8,271 participants (15-17%, depending on correction for participation bias)
had headache yesterday lasting on average for 6 hours. It was bad or very bad in 56% of cases and caused absence
from work or school in 6%. Among those who worked despite headache, 20% reported productivity reduced by
>50%. Social activities were lost by 24%. Women (21%) were more likely than men (12%) to have headache
yesterday, but impact was similar in the two genders.
Conclusions: With recall biases avoided, our findings indicate that headache costs at least 0.7% of working capacity
in Europe. This calculation takes into account that most of those who missed work could make up for this later,
which, however, means that leisure and social activities are even more influenced by headache.
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The World Health Organization (WHO) has acknow-
ledged headache disorders as of global public-health im-
portance [1]. This is good for people with headache,
who carry most of its burden but who find that it re-
ceives little priority in the queue for health care [1].
Headache disorders are under-diagnosed and mostly
undertreated [1,2], not because diagnosis is particularly
difficult or because effective treatments do not exist but
because of widespread failure of health services to re-
cognize the need for health care for headache and to
take steps to deliver it [1,2]. In these circumstances, the
recent Global Burden of Disease Survey 2010 (GBD2010)
[3] found tension-type headache (TTH) and migraine to* Correspondence: t.steiner@imperial.ac.uk
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in any medium, provided the original work is pbe the second and third most prevalent disorders in the
world, and migraine the seventh highest specific cause of
disability [4].
In fact there are large gaps in our knowledge of the
prevalence and burden of headache worldwide [5,6]. In
Europe, knowledge is most complete in western coun-
tries, yet focuses strongly on migraine; rather few studies
have addressed the more prevalent TTH or the more
disabling headache disorders characterized by headache
on ≥15 days/month. Countries to the east, particularly
those of the former USSR, have until recently been badly
neglected.
The Eurolight project was a collaboration of 25 partners
from 15 countries in Europe [7] supported by the EC
European Agency for Health and Consumers. Eurolight’s
main objective was to bolster the political argument for
better investment in health-care services for people withan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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to adduce evidence of the impact of migraine, TTH and
headache on ≥15 days/month across the EU, and achieved
this by conducting surveys in ten countries. It added esti-
mates of impact to those of prevalence [8], thereby filling
an important part of the knowledge gap in Europe, and
showed, among other large burdens, the enormous finan-
cial costs (over €100 billion annually) imposed by head-
ache disorders [9].
Burden-of-headache studies generally estimate 1-year
prevalence and enquire into quantifiable components of
burden (for example, symptom burden, disability, time
loss, financial loss, impact on quality of life) through ques-
tionnaires that depend upon recall over a preceding period
(commonly 3 months). It is not known how reliable recall
is for such matters, but at best it is likely to be variable
and at worst highly misleading [10]. Recent studies ini-
tiated by the Global Campaign against Headache [5] in
Russia [11], China [12,13], India [14], Pakistan [15] and
Zambia (unpublished) introduced enquiry into “headache
yesterday”, and Eurolight followed this lead. In such an
enquiry, numbers responding positively are obviously
reduced: the prevalence of headache yesterday is sub-
stantially lower than the 1-year prevalence, given that
headache-affected days vary in frequency between in-
dividuals with headache from one to 365 per year. On the
other hand, responses to enquiries about headache yester-
day are not subject to recall bias.
The full methodology [7,16] and principal results [8]
of Eurolight are published elsewhere. Here are presented
the results on headache yesterday.Methods
Eurolight was essentially an EU-wide study employing
a modified and pragmatic form of cluster sampling to
reach a large number of participants in many coun-
tries. Questionnaire-based surveys were conducted in
10 countries: Austria, France, Germany, Ireland, Italy,
Lithuania, Luxembourg, Netherlands, Spain and United
Kingdom (UK).Ethics
The National Ethics Committee of Luxembourg gave over-
all approval of the protocol. Further approvals were ob-
tained from national or local ethics committees wherever
needed as the methods for recruitment of participants dif-
fered between countries. Similarly, data protection ap-
provals were obtained centrally in Luxembourg and at
country levels in compliance with national and European
privacy laws.
In each country, prospective participants received a
written information sheet explaining the project and en-
quiry, and their purpose.Questionnaire
The development, content and validation of the structured
questionnaire, and its translation into all local languages,
have been previously described [16]. Demographic, scree-
ning (for headache) and headache-diagnostic questions
(based on ICHD-II [17]) were supplemented by several
question sets addressing impact. Duration of headache
yesterday was recorded categorically (<1, 1-4, 5-12 or >12
hours). Intensity of headache yesterday was graded on a
verbal rating scale (“not bad”, “bad” or “very bad”, these
being terms that lent themselves better to translation than
the customary “mild”, “moderate” or “severe”). Absence
from work or school yesterday because of headache was
recorded in three categories (“less than half” or “more
than half the day” or “all day”). In those who worked yes-
terday despite headache, two further questions enquired
into functional impairment: the first asked how much, of
that expected to be done, was actually done (“everything”,
“more than half”, “less than half” or “nothing”); the second
asked whether any shortfall would be made up for later
(“yes” or “no”). Final questions were about household
chores and planned social activities actually done yester-
day despite headache (“everything”, “more than half”, “less
than half” or “nothing” in either case).Sampling and data collection
Methods varied between countries according to what was
feasible. Again, these are fully described elsewhere [7].
Table 1 provides a summary. The sample drawn from
Lithuania was fully population-based. In other countries,
samples were to varying degrees less population-based.
Additional surveys in Spain and the Netherlands, and
the only survey in Ireland, were performed among mem-
bers of the national headache patients’ organizations.
The samples generated from these were inevitably biased
[7] and the data from them are not used here. Conse-
quently, only nine countries contributed to the analysis.The non-responder study
In all countries, questionnaires were more likely to be
completed and returned by those most affected by head-
ache (participation bias), and thus would not be represen-
tative of the initial samples (particularly relevant because
of the rather low participation rates in some countries).
Therefore, studies of non-responders were performed
in Luxembourg (n = 357), Italy (n = 202), Netherlands
(n = 188) and Germany (n = 260). In Italy, non-responders
were invited by means of advertisements in local news-
papers to complete a short questionnaire on the website
of Centro Italiano di Ricerche Neurologiche Applicate
(CIRNA) (http://www.cefalea.it). In the other countries,
non-responders were selected randomly and called by
telephone. All were asked whether headache had occurred
Table 1 Summary of data collection methods in each country
Country* Sample size (n) Methods
Lithuania 1,137 Sample drawn from inhabitants of Kaunas city and Kaunas region using Residents’ Register Service, reflecting age
(in range 18-65 years) and gender composition of Lithuania and proportions living in rural (33%) or urban (67%)
areas. Data collection face-to-face, conducted by medical students “cold-calling” door-to-door.
Luxembourg 6,498 Sample aged 18-65 years, stratified for age, gender, region and nationality, drawn from general population via
national social security registry (IGSS). Questionnaires distributed and returned by post. Reminders sent one month
later to non-responders.
Spain 1,700 Random sample of employees of various companies operating in national postal services in 10 areas of Spain,
stratified to be representative of general working population with regard to gender, age (within range 18-65 years)
and education. Ten occupational health physicians delivered and took return of questionnaires. One reminder by
telephone to non-responders.
Germany 3,000 Random urban (50%) and rural (50%) samples aged 18-65 years from general population listings supplied by local
municipal authority. Questionnaires distributed and returned by post. No reminders sent.
Italy 3,500 Random urban (70%) and rural (30%) samples drawn from general population using listings supplied by Azienda
Sanitaria Locale of Pavia, stratified with regard to gender, age (in range 18-65 years) and education. Questionnaires
distributed and returned by post. No reminders sent.
France 2,400 Consecutive patients aged 18-65 years attending any of cooperative of 80 general practitioners (GPs) on a pre-
specified day. Questionnaires to be completed and returned immediately or later by post. One reminder by email
after one week to non-responders.
Austria up to 6,000 Up to 10 consecutive patients aged 18-65 years visiting any of 400 GPs and 200 neurologists for any reason on a
pre-specified day. Questionnaires to be completed and returned later. One reminder after one month to non-
responders.
Netherlands unknown Survey conducted by TNS-NIPO, a market research company with access to a population sample of 200,000,
representative with regard to gender, age (in range 18-65 years), region and education. Questionnaire distributed by
internet, to be completed on-line. Study stopped when >2,000 received back.
UK 720 Modified population-based sampling attempted through 12 GP practices in 11 areas (in UK, virtually all residents are
registered with local GP). Questionnaire given to consecutive patients aged 18-65 years attending for any reason
over a period of time, to be completed and returned immediately, or later by post.
*Countries are listed in descending order corresponding to how well the sample was population-based.
Table 2 Numbers and gender of participants by country
Country Participants (n) Male: female (%)
Austria 644 30:70
France 876 32:68
Germany 318 43:57
Italy 487 42:58
Lithuania 573 41:59
Luxembourg 1,833 41:59
Netherlands 2,414 50:50
Spain 999 41:59
United Kingdom 127 35:65
Overall 8,271 42:58
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yesterday (yes or no).
Data management and analysis
All completed questionnaires were transferred electro-
nically to the data-management centre at CRP-Santé.
Double-data-entry and reconciliation of inconsistencies
were employed as quality-control procedures.
Statistical analyses were performed at CRP-Santé using
SAS version 9.2, and the further calculations of results
described in the text were performed by LJS, using Excel
version 14.0.6123.5001. Many analyses were purely de-
scriptive. Not all participants answered the questions on
headache yesterday; to determine the prevalence of
headache yesterday, the denominator was taken as all
those who returned questionnaires, with or without these
questions answered, which gave a more conservative es-
timate. Prevalence estimates were adjusted for gender
imbalance: since more women than men returned ques-
tionnaires, the overall prevalence was calculated as the
weighted mean of the prevalences estimated separately for
men and women.
Results
In nine countries, 8,271 participants not derived from
specific headache-patient populations (ie, excluding thepatient-organization samples from the Netherlands, Spain
and Ireland), participated in the survey. A majority (58%)
were female. For each country, the number of participants
and their gender are shown in Table 2. The overall par-
ticipation rate in the study (excepting the Netherlands,
where the denominator was indeterminable, and Austria,
where it was not recorded) was 27% (details are reported
elsewhere [7]).
Altogether, 1,422 participants (17.2%) reported head-
ache yesterday. The prevalences of headache yesterday
in the nine countries were rather constant in the main
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(gender-adjusted mean: 17%; SD: 0.4%), with the UK,
which had very low numbers, appearing as an outlier
(25%) (Figure 1). In the non-responder study, with
1,007 participants, there were 91 (9.0%) with headache
yesterday.
Most participants (47%) reported a duration of head-
ache yesterday of 1-4 hours, which might reflect effect of
treatment; 24% reported 5-12 hours and 15% reported
>12 hours. The estimate of the overall mean (taking the
mid-point of each range) was 6 hours (Table 3). In all
samples, most headache yesterday was reported as “not
bad” (overall mean 44%) or “bad” (overall mean 44%);
even so, headache yesterday was “very bad” in 11%.
Functional impairment yesterday because of headache
showed that most people (72%) were adversely affected
to some extent, while about a quarter (overall mean
27%) were severely affected (could do less than half of
what they expected) and a minority (overall mean 7%)
could do nothing (Table 3). Variation between countries
was not enormous (Figure 2). Yesterday was a workday
for 51% of those with headache yesterday. Absence rates
from work were more variable but, again overall, 6% of
those with headache yesterday (or 0.5% of all partici-
pants) lost the entire day. Of those who worked yester-
day despite headache, 20% did less than half or nothing
of what they expected, and only a small majority (55%,
somewhat more than the 28% reporting normal func-
tion) responded that they actually did everything. Of
those who did less, the majority (71%) claimed they would
be able to make up for it later. The pattern was somewhat
different for household chores, with fewer people (36%)0
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Figure 1 Prevalence of headache yesterday in nine European countrieachieving everything expected and more (11%) doing
nothing, and for social activities (33% achieving every-
thing, 24% doing nothing).
The prevalence of headache yesterday was much higher
in women than in men (21% vs 12%). However, with re-
gard to headache duration and intensity and the measures
of functional impairments, men and women were quite
similar (Table 3).
Discussion
The importance of measuring the impact of headache
yesterday, and the major strength of this study, lies in
the freedom from recall bias. This form of bias poten-
tially affects all studies retrospectively recording impact
over a period of time, to an unknowable degree. We em-
phasise the distinction between recall error and recall
bias. Recall of what happened yesterday may not be
error-free, but the error is likely to be neither systematic
nor large enough that it might lead to bias. There may
be exaggeration, or mis-description in other ways, but
these are not forms of recall bias, and they occur in any
enquiry.
What happened yesterday is not, of course, indicative
of the impact of headache in most individuals, but at
population level it is. Numbers of participants contribut-
ing data are much reduced when the focus is on head-
ache yesterday, but this is countered effectively here by
the large original numbers in this study. The impact of
headache yesterday therefore, we believe, robustly and
accurately describes the impact of headache overall.
The collection of data from multiple samples drawn
from nine countries in Europe yielded results relevantFra
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Table 3 Prevalence, duration and impact of headache yesterday in nine European countries
Overall Males Females
Headache yesterday (HY) (% [CI]) 17 [16-18] 12 [11-13] 21 [20-22]
(n/N of participants in the study) 1,422/8,272 414/3,456 1,007/4,791
Duration of HY (median) (hr) 6 5 6
Intensity of HY (“bad” or “very bad”) (%) 56 52 58
Functional impairment during HY (severely affected or could do nothing) (%) 34 32 35
Lost all day at work or school because of HY (% [CI]) 6 [4-8] 7 [4-11] 5 [4-7]
(n/N of participants for whom yesterday was a workday) 41/726 15/217 26/509
Worked with HY, but did nothing or < half of expected (% [CI]) 20 [17-23] 18 [13-24] 20 [17-24]
(n/N of participants who worked with HY) 134/683 36/204 98/479
Lost all day from household chores because of HY (% [CI]) 11 [10-13] 13 [10-16] 11 [9-13]
(n/N of participants responding) 167/1,453* 53/415* 114/1,038*
Lost all social activities yesterday because of HY (% [CI]) 24 [22-27] 22 [18-26] 25 [23-28]
(n/N of participants responding) 351/1,442* 90/416* 261/1,026*
CI: 95% confidence interval.
*some people answered this question although they had not answered “yes” to the question about headache yesterday (numerator n in first row of the table).
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tries. This was the intention. We have presented some
limited graphical comparisons between countries, but
emphasise that there are methodological limitations in-
herent in a study of this sort. Not all samples were
population-based, although differences that might be at-
tributable to this were, perhaps surprisingly, not very ap-
parent: variations between countries were not unduly
large. Nevertheless, our data should not be used to make
comparisons between the nine countries because of the
differences in sampling and data collection methods in0
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Figure 2 Percent of people with severely impaired working capacity a
European countries.each, and, importantly, the relatively small sample sizes
in some of them.
Although diagnostic questions were included in the
methods, the responses to these are not analysed here.
This is mostly because these questions were applied to
the subjectively most bothersome headache reported in
the last year, not to headache yesterday. Although we
asked whether headache yesterday was of the same type
as the most bothersome, and in over two thirds (69%) of
cases it was, there was no diagnosis made in the remai-
ning 31%. This is not important to our message, whichnc
e
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l
could do < half
could do nothing
mong those with headache yesterday in nine
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on migraine, are a major cause of population ill-health,
representing a need for which health services must make
due provision.
A potential source of bias was headache today: partici-
pants with headache on the day they encountered the
questionnaire might have deferred responding until they
became headache-free, and then been highly likely to re-
port headache yesterday. Headache today is as probable
as headache yesterday; therefore, it might seem that this
factor could double the reported prevalence of headache
yesterday. In reality this was not so, because about half
of the 1-day prevalence of headache is attributable to
daily headache (the probability of episodic headache yes-
terday is <7% [ie, 2/30] of its long-term prevalence, as-
suming an average frequency of 2 days/month, whereas
the probability of daily or near-daily headache being
present yesterday is close to 100% of its prevalence).
When headache occurs daily, it is of no consequence
whether the enquiry is conducted today or tomorrow.
The problem would not have occurred in Lithuania, where
participants were visited without prior notice, and did not
have the option of deferring their responses until tomor-
row. The reported prevalence of headache yesterday was
lowest in this country, but not outlying (Figure 1).
Low participation rates did inject bias. The purpose of
the non-responder study was to detect participation bias,
which, according to this study, led to an over-estimation
of the prevalence of headache yesterday. However, the
non-responder study had relatively few numbers, and a
much less-detailed enquiry; the data from it were of
lower quality than those from the main study. It would
be quite inappropriate to substitute the former for the
latter; rather, the former might be considered to demar-
cate minima. Responders in the main study, of whom
79% reported headache last year, were 27% of the sur-
veyed sample (this being the participation rate); the non-
responder study therefore represented the other 73%, of
whom 64% (gender-adjusted) had headache last year [8].
The weighted average of 68% ([79*27 + 64*73]/100) es-
tablishes the minimum 1-year prevalence. We assumed
that headache yesterday could occur only in those re-
porting headache last year, and adjusted on this basis. In
the continuing discussion below, ranges are presented
that reflect this.
An estimated 15-17% (the lower limit = 17*68/79) of
adults aged 18-65 years in Europe had headache yester-
day, which implies a similar percentage every day and
signals a huge level of population ill-health. This range
should be internally consistent with the approximate es-
timate derived from the 1-year prevalence (78.6% [8])
and average frequency (5.8 headache days/month [un-
published]) in the same population. These data generate
a mean of 459 headache days per month per 100 of thepopulation, from which it can easily be calculated that
15% of the population have headache on any day (13%
when potential participation bias is considered). These
figures are reassuringly similar, despite being subject to
recall bias. Few other data exist on headache on any sin-
gle day; there is one recent study from mainland China
specifically on headache yesterday, reporting an age-
adjusted prevalence of 4.8% in the general population
aged 18-65 years [13]. This is a little less than one third
of our finding, but the estimated 1-year prevalence of
headache in China (23.8% [18]) is also about a third of
that in Europe [14]. Our finding of 15-17% for headache
yesterday in Europe is consistent with the point preva-
lences (16 and 19%) found in two carefully conducted
Danish studies [19,20].
The purpose of reporting headache yesterday was,
however, to focus not on prevalence but on impact. Dur-
ation and intensity are dimensions of symptom burden;
whilst they may be misleading because they are reported
subject to the effects of any treatments taken, they give
rise to the following estimation. If 15-17% of a popula-
tion had headache yesterday of average duration 6 hours,
then one quarter of these (say 4.0%) had headache at any
particular moment (which compares with 1.8% reported
in China [13]). Headache was bad or very bad in 56% of
those with headache, or 2.2% of the population aged
18-65 years (1.4% in China [13]). Taking the popula-
tion of the EU in the age range 18-65 years as 300 mil-
lion (http://europa.eu/about-eu/facts-figures/living/), we
calculate that, at this and any moment, between 6.3
(300*0.56*0.15/4) and 7.1 (300*0.56*0.17/4) million people
are suffering in Europe with bad or very bad headache.
As telling are the secondary effects – in particular,
functional impairment and its consequences. Thus, an
estimated 0.4 (0.5*68/79) to 0.5% of working-age adults
in Europe lost the whole of yesterday at work because of
headache, again implying a similar percentage every
(working) day. A further 1.2-1.6%, working despite head-
ache yesterday, reported a significant level of inefficiency
(less than half or nothing achieved). In line with the the-
ory behind the MIDAS instrument [21] on which our
lost-productivity questions were based, we counted these
also as wholly lost days: the overestimate arising from
this was offset by discounting days when >50% but <100%
was achieved. Adding these generates a range-estimate of
1.8-2.1% as the total lost productivity at work due to head-
ache yesterday (and every working day). This is not so very
different from the 1.3% reported in China [13], despite the
much lower prevalence there, reflecting a higher propor-
tion in China reporting disablingly bad headache. Further-
more, in our study, 72% of participants working with
impaired efficiency believed they could make up for it
later. If so, a reduction by this factor should be applied to
this element of lost time (now 0.3-0.4%), yielding a revised
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ing up later” can achieve complete restitution, but clearly
there must be some degree of offsetting. In other words,
at least 0.7% of the available working capacity in Europe,
and possibly 2-3 times this, is surrendered to headache,
which opens a window upon a vista that employers and
governments both should find alarming.
The evidently greater negative impact of functional
impairment upon household chores and social activities
(Table 3) reflects, almost certainly, the more optional na-
ture of these in comparison with duties at work. They
are more easily abandoned or reduced, which should not
be to underrate their importance as a part of everyday life
that headache takes away. Given the number of people
with headache yesterday, losses of this sort must be ac-
knowledged because their cumulative impact is very high.
And there is more: for the 72% of affected participants
who could make up later for impaired efficiency at work,
something else would presumably be given up in order to
do this. There would remain a possibly immeasurable but
not necessarily intangible loss expressed elsewhere, and in
all probability this would be of leisure time, already a ser-
ious casualty of headache. While lost working time has, in
theory at least, a calculable financial consequence (either
wages are lost or the employer pays for work not done),
how leisure time is valued in monetary terms is a complex
subject which we will not attempt to explore. It should
nonetheless be noted that any value attached to lost leis-
ure time must be added to that of lost work time when
the cost of headache is calculated.
Our data show that the burden of headache is much
larger in women than in men, mostly because women
have headache more often. During headache, men and
women appear to have similar symptom burdens and
functional impairment.
Conclusion
Headache is common, and its impact is high. Assess-
ment in nine countries in Europe based on headache
yesterday, and therefore free from recall bias, shows that
headache affects 15-17% of adults aged 18-65 years on
any day. It removes at least 0.7% (and up to three times
this) from workforce capacity. Leisure time and social
activities are also serious casualties.
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